Adell Harriman & Carpenter Inc. Decreases Holdings in iShares Biotechnology ETF $IBB

Adell Harriman & Carpenter Inc. cut its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 1.1% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 7,555 shares of the financial services provider’s stock after selling 85 shares during the quarter. Adell Harriman & Carpenter Inc.’s holdings in iShares Biotechnology ETF were worth $956,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Brighton Jones LLC purchased a new position in shares of iShares Biotechnology ETF in the fourth quarter worth $201,000. Sequoia Financial Advisors LLC increased its stake in shares of iShares Biotechnology ETF by 14.9% in the first quarter. Sequoia Financial Advisors LLC now owns 3,684 shares of the financial services provider’s stock worth $471,000 after buying an additional 479 shares during the period. Vontobel Holding Ltd. increased its stake in shares of iShares Biotechnology ETF by 73.1% in the first quarter. Vontobel Holding Ltd. now owns 5,123 shares of the financial services provider’s stock worth $655,000 after buying an additional 2,164 shares during the period. Milestone Investment Advisors LLC increased its stake in shares of iShares Biotechnology ETF by 17.6% in the first quarter. Milestone Investment Advisors LLC now owns 8,102 shares of the financial services provider’s stock worth $1,036,000 after buying an additional 1,212 shares during the period. Finally, North Capital Inc. purchased a new position in shares of iShares Biotechnology ETF in the first quarter worth $101,000. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Performance

IBB stock opened at $156.97 on Thursday. iShares Biotechnology ETF has a 1-year low of $107.43 and a 1-year high of $158.64. The business has a 50 day simple moving average of $146.02 and a two-hundred day simple moving average of $133.75.

iShares Biotechnology ETF Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, September 19th. Shareholders of record on Tuesday, September 16th were paid a $0.0828 dividend. The ex-dividend date was Tuesday, September 16th. This represents a $0.33 dividend on an annualized basis and a yield of 0.2%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.